Dantrolene-Sodium-Hemiheptahydrate shortage — AU supply status & alternatives

Dantrolene-Sodium-Hemiheptahydrate

—

In shortage · Australia

DANTRIUM dantrolene sodium hemiheptahydrate

In declared shortage · 🇦🇺 Australia & also short in🇨🇦 CA🇮🇹 IT

Critical shortage

Reading today’s signals…

✓ Can I substitute?

Yes — under S19A

TGA-approved overseas product

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

Dec 2026

Sponsor est. via TGA

Product attributes reference data we hold

Active ingredient (INN)	Dantrolene-Sodium-Hemiheptahydrate
Brand names	DANTRIUM dantrolene sodium hemiheptahydrate
Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
Controlled substance	No
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

✓

Section 19A approval in force

An overseas registered product containing dantrolene 25mg has been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals

Recalls official enforcement reports

🇺🇸

Dantrolene Sodium Active Pharmaceutical Ingredient Packaged

Attix Pharmaceuticals · Nov 2014

Class IIdetails ↗

🇺🇸

Dantrolene Sodium (Orange) Active Pharmaceutical Ingredient

Attix Pharmaceuticals · Nov 2014

Class IIdetails ↗

🇺🇸

Dantrolene Sodium (Light Yellow) Active Pharmaceutical Ingre

Attix Pharmaceuticals · Nov 2014

Class IIdetails ↗

Verified timeline regulator events

🇦🇺 10 July 2026

critical reported

🇦🇺 29 June 2026

critical reported

🇨🇦 1 June 2026

high reported

🇨🇦 4 May 2026

high reported

🇨🇦 20 Apr 2026

high reported

🇦🇺 12 Jan 2026

Shortage resolved

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.